NYSE:JNJ (USA) Also Trade In: Argentina Austria Brazil Chile Germany Mexico Peru Switzerland UK

Johnson & Johnson $ 162.38 -0.4 (-0.25%)

Volume:

6,741,521

Avg Vol (1m):

7,763,522

Market Cap $:

427.47 Bil

Enterprise Value $:

434.45 Bil

P/E (TTM):

25.53

P/B:

6.64

5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

View Full Chart

What is PE Ratio (TTM)?

Current and historical daily P/E ratio for JNJ (Johnson & Johnson) from 1990 to Jan 20 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Johnson & Johnson stock (JNJ) PE ratio as of Jan 20 2021 is 25.53. More Details

Johnson & Johnson PE Ratio (TTM) Chart

EMBED

Johnson & Johnson PE Ratio (TTM) Historical Data

View and export this data going back to 1990. Start your Free Trial

Total 1256

Johnson & Johnson PE Ratio (TTM) Historical Data
Date	PE Ratio (TTM) Data	Date	PE Ratio (TTM) Data
2021-01-21	25.5	2020-11-19	23.1
2021-01-20	25.5	2020-11-18	23.2
2021-01-19	25.6	2020-11-17	23.5
2021-01-18	25.2	2020-11-16	23.7
2021-01-15	25.2	2020-11-13	23.6
2021-01-14	25.3	2020-11-12	23.3
2021-01-13	24.8	2020-11-11	23.2
2021-01-12	24.9	2020-11-10	23.3
2021-01-11	25.1	2020-11-09	23.0
2021-01-08	25.2	2020-11-06	22.4
2021-01-07	25.2	2020-11-05	22.0
2021-01-06	25.1	2020-11-04	21.9
2021-01-05	24.9	2020-11-03	21.8
2021-01-04	24.6	2020-11-02	21.8
2021-01-01	24.8	2020-10-30	21.6
2020-12-31	24.8	2020-10-29	21.6
2020-12-30	24.5	2020-10-28	21.8
2020-12-29	24.2	2020-10-27	22.5
2020-12-28	24.1	2020-10-26	22.6
2020-12-25	24.0	2020-10-23	22.8
2020-12-24	24.0	2020-10-22	22.8
2020-12-23	23.9	2020-10-21	22.6
2020-12-22	24.0	2020-10-20	22.7
2020-12-21	24.1	2020-10-19	22.7
2020-12-18	24.3	2020-10-16	23.3
2020-12-17	24.2	2020-10-15	23.1
2020-12-16	23.5	2020-10-14	23.3
2020-12-15	23.7	2020-10-13	23.3
2020-12-14	23.4	2020-10-12	23.9
2020-12-11	24.1	2020-10-09	23.7
2020-12-10	23.9	2020-10-08	23.4
2020-12-09	24.1	2020-10-07	23.3
2020-12-08	23.8	2020-10-06	23.0
2020-12-07	23.4	2020-10-05	23.3
2020-12-04	23.6	2020-10-02	23.0
2020-12-03	23.4	2020-10-01	23.2
2020-12-02	23.3	2020-09-30	23.4
2020-12-01	23.2	2020-09-29	23.1
2020-11-30	22.8	2020-09-28	23.1
2020-11-27	22.6	2020-09-25	25.6
2020-11-26	22.6	2020-09-24	25.4
2020-11-25	22.6	2020-09-23	25.4
2020-11-24	22.6	2020-09-22	25.3
2020-11-23	22.6	2020-09-21	25.5
2020-11-20	23.0	2020-09-18	26.2

Johnson & Johnson PE Ratio (TTM) Comparison

Company	Market Cap(Mil)	PE Ratio (TTM)

Business Description

Industry Healthcare » Drug Manufacturers » NAICS : 325412 NAICS : 2834

Compare NYSE:PFE NYSE:MRK NYSE:ABBV NYSE:LLY NYSE:BMY NAS:AMGN NAS:GILD NYSE:AGN NAS:BIIB NAS:HZNP XSWX:ROG XSWX:NOVN LSE:AZN XPAR:SAN LSE:GSK TSE:4519 FRA:A60 XTER:BAYN SHSE:600276 TSE:4568

Traded in other countries JNJ.Argentina JNJ.Austria JNJB34.Brazil JNJ.Chile JNJ.Germany JNJ.Mexico JNJ.Peru JNJ.Switzerland 0R34.UK JNJ.USA

Address One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933

Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total revenue is generated in the United States.

Product

Business

Information

About

Affiliate Program

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Earn affiliate commissions by embedding GuruFocus Charts

GuruFocus Affiliate Program: Earn up to $400 per referral. Detailed

Disclaimers

GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.